Mylan N.V. (MYL): Guidance Down News

MYL – Sees FY17 EPS of $4.30-4.70 vs. $5.12.


Key Facts Surrounding This News Item


  • MYL had a POWR Rating of D (Sell) coming into today.
  • MYL was -12.26% below its 10-Day Moving Average coming into today.
  • MYL was -15.30% below its 20-Day Moving Average coming into today.
  • MYL was -16.57% below its 50-Day Moving Average coming into today.
  • MYL was -17.40% below its 100-Day Moving Average coming into today.
  • MYL was -17.56% below its 200-Day Moving Average coming into today.
  • MYL had returned -16.67% year-to-date leading up to today’s news, versus a +11.64% return from the benchmark S&P 500 during the same period.

More Info About Mylan N.V. (MYL)


Mylan NV develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company was founded in 1961 and is based in Potters Bar, Hertfordshire. View our full MYL ticker page with ratings, news, and more.

MYL at a Glance

MYL Current POWR Rating™
Overall POWR Rating™
MYL Current Price $30.90 0.59%
More MYL Ratings, Data, and News

MYL Price Reaction

The day of this event (Aug. 9, 2017)
MYL Closing Price$32.08 0.91%
MYL Volume32,038,100
429.95% from avg
Leading up to this event
MYL 1-mo returnN/A%
After this event
MYL 1-day return1.55%
MYL 3-day return7.29%
MYL 5-day return4.33%

MYL Price Chart



More Mylan N.V. (MYL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MYL News
Page generated in 2.3246 seconds.